GLENMEDE TRUST CO NA
BankPosition in SUPN — Supernus Pharmaceuticals, Inc.
CIK 314949
PHILADELPHIA, PA
Position in SUPN
as of Mar 31, 2026
· filed May 26, 2026
Position Value
$11,325,226
-$562,168 QoQ
Shares Held
219,099
-8.4% QoQ
Ownership
0.377%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 94.43736323970192.ToString("F0")%
Shared 0.ToString("F0")%
None 5.562636760298078.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GLENMEDE TRUST CO NA holds $85,307,293 across 13 Drug Manufacturers - Specialty & Generic names. SUPN ranks #4 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
231,874 | $27,409,824 | |
| 2 | ALKS |
Alkermes plc.
|
378,090 | $13,369,261 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
212,461 | $12,592,562 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
219,099 | $11,325,226 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
78,577 | $10,351,733 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
8,052 | $4,774,674 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
80,571 | $1,928,063 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
53,377 | $1,607,715 |
All Filings in SUPN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,325,226 | 219,099 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $11,887,394 | 239,183 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $524,818 | 16,025 | Shares | Sole | 2025-05-15 | |
| 2023-06-30 | $509,396 | 16,946 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $613,953 | 16,946 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $564,405 | 15,823 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $532,934 | 15,744 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $457,137 | 15,807 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,379,812 | 290,217 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,240,048 | 556,929 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $15,033,211 | 563,675 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $17,486,532 | 567,929 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $14,908,488 | 569,461 | Shares | Defined | 2021-05-18 | |
| 2020-12-31 | $12,372,026 | 491,734 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $11,054,785 | 530,460 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $14,534,143 | 611,964 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $14,069,600 | 782,079 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||